Compass OPSS

Compass OPSS Microlearning

Health EN ↓ 20 episodes

This series delivers quick, practical education for busy clinicians on safer opioid prescribing and pain management. Each episode features a real-world case, a clear clinical goal, and actionable strategies to improve patient care. Topics range from opioid rotation and buprenorphine initiation to procedural pain control and emerging concepts like nociplastic pain. Designed for flexibility, these microlearnings are available in video, audio, and written formats to fit your schedule.

Author

Compass OPSS

Category

Health

Podcast website

riverside.com

Latest episode

Mar 25, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Module 20: Addressing Cannabis and Chronic Pain Patients 25.03.2026

This week's case is about a patient, Rick, a 36-year-old male with chronic back and neck pain. He works as a computer programmer, logging long hours in his office chair, which doubles as his gaming chair. He says that if he twists his neck or back the wrong direction, he experiences severe pains across his entire low back and up into his neck. He manages his pain with hydrocodone/apap, 4 tablets a...

Module 19: The Placebo Effect 23.03.2026

This week's case is about a patient, Mary a 50 year old who presents with long standing knee pain for Xray proven moderate osteoarthritis. Mary is interested in trialing a steroid knee injection for her osteoarthritis and has trialed other interventions including OTC medications and lidocaine patches without significant relief. As her clinician you believe that prior to trialing knee injections, p...

Module 18: Identifying Patients at Risk for Opioid Misuse or OUD 16.03.2026

This week's case is about a patient, Danielle, a 54-year-old female, with chronic lumbar radiculopathy taking long-term morphine. Her pain is manageable, but she occasionally requests early refills and denies non-medical drug use. Her urine drug screen is consistent with prescribed opioids only.

Module 17: Managing Opioid Risk and Transitioning to Buprenorphine (Part 3) 09.03.2026

Mary is a 67-year-old woman with chronic pain, diabetic neuropathy, and depression, anxiety, and insomnia. She uses opioids, benzodiazepines, and other medications, and occasionally drinks alcohol to help with sleep.

Module 16: Managing Opioid Risk and Transitioning to Buprenorphine (Part 2) 09.03.2026

Mary is a 67-year-old woman with chronic pain, diabetic neuropathy, and depression, anxiety, and insomnia. She uses opioids, benzodiazepines, and other medications, and occasionally drinks alcohol to help with sleep.

Module 15: Managing Opioid Risk and Transitioning to Buprenorphine (Part 1) 09.03.2026

Mary is a 67-year-old woman with chronic pain, diabetic neuropathy, and depression, anxiety, and insomnia. She uses opioids, benzodiazepines, and other medications, and occasionally drinks alcohol to help with sleep.

Module 14: Reducing High-Risk Controlled Substance Combinations 03.03.2026

This week’s case explores a 35-year-old female with a history of chronic insomnia, anxiety, ADHD, and bipolar disorder. Her current regimen includes PRN alprazolam and twice-daily dextroamphetamine/amphetamine 30mg.

Module 13: Optimizing Safety Through Opioid Dose Reduction 03.03.2026

This week’s case explores a 64 year old male with bilateral above-knee amputations and chronic pain transitioned to this practice in 2018 while on a high-dose regimen exceeding 400 MME. His treatment included OxyContin, oxycodone IR, and alprazolam.

Module 12: Transitioning from Long-term Methadone to Buprenorphine 23.02.2026

This week’s case explores a 54 year old female with chronic pain transferring to a new practice in December of 2021 after her provider lost his license. She had been on methadone for well over a decade and had already been tapered down to 50mg per day (235 MME) in divided doses. She came in wanting to transition to buprenorphine.

Module 11: Managing Persistent Opioid Withdrawal 23.02.2026

This week's case is Kent, a 72-year-old male, on long-term opioid therapy for Persistent Spinal Pain Syndrome- Type 2 (formerly called failed back surgery syndrome). Over the last 18 months, you have been working collaboratively to slowly wean him down from a prior regimen of MS Contin 30 mg BID and hydrocodone plus acetaminophen, 5/325 mg, 8 tablets/day. (Total MME of this regimen: 100). He is no...

Module 10: Transitioning from Hydrocodone to Buprenorphine 17.02.2026

This week’s case explores a 70-year-old patient with a remote history of heroin use disorder who had been stable for years on hydrocodone as part of a multimodal chronic pain treatment plan. After experiencing a sudden and severe worsening of pain, sleep disruption, and emotional distress, opioid-induced hyperalgesia became a suspected contributor. This case highlights the importance of trauma-inf...

Module 9: Naloxone and Overdose Prevention 09.02.2026

This week's case is about Claire, a 62-year-old woman with osteoarthritis and chronic low back pain who takes hydromorphone ER 8 mg twice daily and gabapentin. This equates to approximately 80 MME/day. She occasionally uses a sleeping pill (temazepam) at night. She lives with her husband, who worries about accidental overdose. They have heard about naloxone but think it is only for people who misu...

Module 8: Urine Toxicology Testing (Part 2) 02.02.2026

Part two: This week's case is about a patient, Tania, a 37- year-old female with chronic pain from lupus vasculitis and peripheral neuropathy. She has episodes of severe abdominal pain and describes intermittent electrical sensations in her legs and feet. Medications include hydroxychloroquine and azathioprine for lupus, duloxetine and bupropion for depression, and meloxicam, gabapentin, and lidoc...

Module 7: Urine Toxicology Testing (Part 1) 26.01.2026

This week's case is about a patient, Tania, a 37- year-old female with chronic pain from lupus vasculitis and peripheral neuropathy. She has episodes of severe abdominal pain and describes intermittent electrical sensations in her legs and feet. Medications include hydroxychloroquine and azathioprine for lupus, duloxetine and bupropion for depression, and meloxicam, gabapentin, and lidocaine patch...

Module 6: Identifying Opioid Use Disorder and Starting Buprenorphine 20.01.2026

his week’s case is about Bob is a 50-year-old man with chronic low back pain who has been taking oxycodone ER 20 mg three times daily for three years. He recently asked for early refills, reports lost prescriptions twice, and his urine drug screen shows fentanyl and benzodiazepines. The state prescription drug monitoring program indicates prescriptions from multiple providers. This constellation o...

Module 5: Maximizing the Controlled Substances Agreement 13.01.2026

This week’s case is about David, who is a 65- year-old male with chronic pain from severe degenerative osteoarthritis of the cervical and lumbar spine. He takes extended-release oxycodone 20 mg twice a day, supplemented with immediate-release oxycodone 10 mg up to 4 times daily. The regimen has been unchanged for 8 years. Over that time, he has occasionally run out of his immediate release prescri...

Module 4: How to Taper a Patient From a High Dose of Clonazepam 02.01.2026

This week’s case is about Andrea, a 67-year-old woman with anxiety and insomnia who has been taking high-dose clonazepam for years, also takes citalopram and occasionally drinks alcohol, and is seeking support to safely reduce her medication, highlighting the importance of careful assessment, shared decision-making, and a structured taper.

Module 1: Standard Rotation to Buprenorphine from Chronic Full Agonist Opioid Therapy 17.12.2025

This week's case is about a patient, John, currently prescribed OxyContin 40 mg every 12 hours and hydrocodone/acetaminophen 10-325 mg, two tablets three times daily, totaling approximately 180 MMEs per day. The patient is being considered for a transition to buprenorphine for chronic pain management using a standard rotation approach. We'll walk through the clinical reasoning, dosing strategy, an...

Module 3: Nociplastic Pain 15.12.2025

This week’s case is about Edward, who is a 45 y/o male patient experiencing chronic abdominal pain for over five years. The patient has had multiple CT scans, endoscopies, and other procedures without clear etiology of pain – his GI doctor has diagnosed him with irritable bowel syndrome and painful, daily chronic abdominal migraines. The patient has tried multiple medications – and is currently on...

Module 2: Trigger Points and Trigger Point Injections 15.12.2025

This week’s case features Greg, a 42-year-old male patient, who while lifting a box at work developed sudden lumbar back pain, which is non-radiating but debilitating. The patient was seen in the ER, where he was diagnosed with a back strain, and provided with prescriptions for cyclobenzaprine and lidocaine patches. In addition, the patient has been using over-the-counter NSAIDS and Acetaminophen...

Listen to the Compass OPSS Microlearning podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.